Загрузка...
High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
BACKGROUND: The subtype of claudin-low breast cancer can be reliably determined only by gene-expression profiling. Attempts have been made to develop immunohistochemical surrogates, which nearly always focus on membranous claudin expression. METHODS: We assessed the immunohistochemical expression of...
Сохранить в:
| Опубликовано в: : | BMC Cancer |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389078/ https://ncbi.nlm.nih.gov/pubmed/29482498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4141-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|